22nd Century Group, Inc. is an agricultural biotechnology firm dedicated to mitigating the risks associated with tobacco use and improving health and wellness through advanced plant science. The company serves the life science and consumer product sectors. Its innovations include ultra-low nicotine tobacco and cigarette offerings, marketed under the VLN King and VLN Menthol King brands, as well as SPECTRUM research cigarettes used in independent scientific investigations. Furthermore, 22nd Century Group collaborates with Keygene N.V. to cultivate hemp and cannabis plants engineered for…
WATCHLIST OCT 22 2026 Benzinga PreMarket Gainers (% change and volume) $GIXI $STAK $BHVN $BKYI $TSLL $XXII $SAIQ $LITZ Read our Benzinga Review here: https://t.co/DbZGLBN9ND https://t.co/jiSS7c0oaL
Consensus price target: $135.00 (+62400% upside from $0.22)
| Fiscal year | Revenue | Revenue YoY | Net income |
|---|---|---|---|
| 2025 | $7.05M | -40.65% | $-5.05M |
| 2024 | $11.88M | -63.12% | $-15.16M |
| 2023 | $32.2M | — | $-140.78M |
Stock data for XXII: Summary · AI Insight · Feed · News · Financials · Transcript · SEC Filings · Insider · Politics